drugset / Trial / NCT03830957

Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

NCT03830957

RandomizedParallel-groupDouble-blindSupportive care

Summary

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.

Timeline

Start
2018-11-26
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivabradine Small molecule 7.5 mg Oral
Comparator Metoprolol Other / unclassified 5 mg Oral